XML 45 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Equity (Tables)
 6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
Schedule of Share Repurchases
Share repurchases for the periods ended June 30 were as follows: 
(in millions, except average price)
Three Months
 
Six Months
 
2019
 
2018
 
2019
 
2018
Total number of shares purchased 1
—

 
—

 
3.4

 
5.0

Average price paid per share 2
$
—

 
$
—

 
$
184.51

 
$
178.11

Total cash utilized
$
—

 
$
—

 
$
644

 
$
1,100


1 
The six months ended June 30, 2019 and 2018 include shares received as part of our accelerated share repurchase agreements described in more detail below.
2 
Average price paid per share information does not include the accelerated share repurchase agreements as discussed in more detail below.
Schedule of Redeemable Noncontrolling Interest
Changes to redeemable noncontrolling interest during the six months ended June 30, 2019 were as follows:
(in millions)
 
Balance as of December 31, 2018
$
1,620

Net income attributable to noncontrolling interest
84

Capital contribution from noncontrolling interest
36

Distributions payable to noncontrolling interest
(72
)
Redemption value adjustment
222

Balance as of June 30, 2019
$
1,890
Schedule of Changes in the Components of Accumulated Other Comprehensive Loss
The following table summarizes the changes in the components of accumulated other comprehensive loss for the six months ended June 30, 2019:
(in millions)
Foreign Currency Translation Adjustment
 
Pension and Postretirement Benefit Plans
 
Unrealized Gain (Loss) on Foreign Forward Exchange Contracts
 
Accumulated Other Comprehensive Loss
Balance as of December 31, 2018
$
(339
)
 
$
(407
)
 
$
4

 
$
(742
)
Other comprehensive income before reclassifications
5

 
(3
)
 
4

 
6

Reclassifications from accumulated other comprehensive loss to net earnings
—

 
89

1 
(4
)
2 
85

Net other comprehensive income
5

 
86

 
—

 
91

Balance as of June 30, 2019
$
(334
)
 
$
(321
)
 
$
4

 
$
(651
)
1 
Reflects amortization of net actuarial losses and is net of a tax benefit of $28 million for the six months ended June 30, 2019. See Note 6 — Employee Benefits for additional details of items reclassed from accumulated other comprehensive loss to net earnings.
2 
See Note 5 — Derivative Instruments for additional details of items reclassed from accumulated other comprehensive loss to net earnings.